Medical Devices - Orthopedic Reconstructive Products
Strategic Profile
Zimmer Biomet is transitioning to a fully dedicated U.S. sales force, expecting short-term disruption but betting on long-term productivity and durable growth gains post-2027. In 2025, the company delivered $8.23 billion in revenue and announced a $1.5 billion share repurchase program.
Cyborg Score Rationale
The company has demonstrated solid financial metrics with $8.011 billion in revenue, an 18.69% operating margin, and 10.05% net margin, indicating efficient management and strong profitability. However, 2026 guidance reflects near-term headwinds from the U.S. sales force transition, with organic growth projected at 1-3%.
Top Insights
Q4 2025 net sales of $2.24 billion grew 10.9% YoY, driven by strong hip and knee implant demand, with adjusted EPS of $2.42 exceeding expectations.
Margin contraction and operating pressure from costs and tariffs reduce near-term earnings leverage and explain management's conservative 2026 guidance tone.
The company has surpassed street earnings estimates in each of the past four quarters, demonstrating consistent operational execution.
Strong balance sheet with a current ratio of 2.43 and debt-to-equity ratio of 0.64 indicates healthy liquidity and manageable debt levels.
Named Competitors
DePuy Synthes — Orthopedic reconstructive and trauma devices
Stryker — Orthopedic implants and surgical equipment
Smith & Nephew — Orthopedic and trauma device manufacturer
Recent Developments
(February 2026) Updated FY 2026 earnings guidance to $8.30-$8.45 EPS and $8.4-$8.6 billion revenue, slightly below consensus estimates.
(February 2026) Reported Q4 2025 earnings beat with adjusted EPS of $2.42 and revenue of $2.24 billion, up 10.9% YoY.
(February 2026) Board approved $1.5 billion stock repurchase authorization effective February 9, 2026 with no expiration date.
Open the full interactive Zimmer Biomet Holdings, Inc. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.